Sichuan Huiyu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is LEUCOVORIN CALCIUM, with a corresponding US DMF Number 40427.
Remarkably, this DMF maintains an Active status since its submission on September 04, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 18, 2024, and payment made on September 19, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II